Company / CapEx per Share
Aligos Therapeutics, Inc. CapEx per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.04
FY2024
5-year range
$0.02 / $0.05
FY2020-FY2024
Trend
+97.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.02 to $0.04 over the past 2 years.
Based on SEC 10-K filings.
0.04 in FY2024 with a 3-year CAGR of -7.2%.
Improved from $0.02 to $0.04 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, capex per share increased 97.0% year-over-year.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.04 | +97.0% |
| FY2023 | $0.02 | +5.1% |
| FY2022 | $0.02 | -61.4% |
| FY2021 | $0.05 | -92.4% |
| FY2020 | $0.71 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026